88 related articles for article (PubMed ID: 6609251)
1. [In vitro antibacterial activity of cefoperazone].
Watanabe Y; Minami S; Yotsuji A; Araki H; Yasuda T; Saikawa I
Jpn J Antibiot; 1983 Dec; 36(12):3437-43. PubMed ID: 6609251
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
Deguchi K; Yokota N; Koguchi M; Fukayama S; Nishimura Y; Nakane Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1987 Oct; 40(10):1752-61. PubMed ID: 3444015
[TBL] [Abstract][Full Text] [Related]
3. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
[TBL] [Abstract][Full Text] [Related]
4. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].
Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689
[TBL] [Abstract][Full Text] [Related]
5. [In vivo antibacterial activity of cefoperazone in intraperitoneal infections in mice].
Minami S; Yotsuji A; Nakashima H; Watanabe Y; Yasuda T; Saikawa I
Jpn J Antibiot; 1983 Dec; 36(12):3444-9. PubMed ID: 6325754
[TBL] [Abstract][Full Text] [Related]
6. [Effects of sulbactam on the activity of cefoperazone against various clinical isolates].
Uete T; Matsuo K
Jpn J Antibiot; 1989 Apr; 42(4):896-909. PubMed ID: 2769941
[TBL] [Abstract][Full Text] [Related]
7. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
[TBL] [Abstract][Full Text] [Related]
8. Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison.
Wise R; Andrews JM; Bedford KA
J Antimicrob Chemother; 1981 Apr; 7(4):343-52. PubMed ID: 6454675
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
[TBL] [Abstract][Full Text] [Related]
10. [In vitro susceptibility to cefoperazone and sulbactam/cefoperazone combination of bacterial strains isolated from various patient materials].
Aksoy AM; Ozsan M; Ural O; Ekmen H
Mikrobiyol Bul; 1993 Jul; 27(3):216-20. PubMed ID: 8361410
[TBL] [Abstract][Full Text] [Related]
11. Induction of cephalosporinase production by various penicillins in enterobacteriaceae.
Minami S; Matsubara N; Yotsuji A; Araki H; Watanabe Y; Yasuda T; Saikawa I; Mitsuhashi S
J Antibiot (Tokyo); 1983 Oct; 36(10):1387-95. PubMed ID: 6358172
[TBL] [Abstract][Full Text] [Related]
12. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
Uete T; Matsuo K
Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
[TBL] [Abstract][Full Text] [Related]
13. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
Abe T; Sato Y; Sei M
Jpn J Antibiot; 2003 Dec; 56(6):574-83. PubMed ID: 15007873
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibility of clinical isolates to aztreonam].
Asari S; Horikawa M; Tsukamoto H; Kouda K; Hayashi C; Miyai K
Jpn J Antibiot; 1987 Jul; 40(7):1317-31. PubMed ID: 3479624
[TBL] [Abstract][Full Text] [Related]
16. [Antibacterial activity of cefoperazone against anaerobic bacteria (author's transl)].
Imamura H; Kobayashi T; Murata K; Kohbata S; Watanabe I; Marui T; Watanabe K; Ninomiya K; Ueno K; Suzuki S
Jpn J Antibiot; 1980 Nov; 33(11):1171-82. PubMed ID: 6454011
[TBL] [Abstract][Full Text] [Related]
17. [beta-lactamase-producing activity and antimicrobial susceptibility of major pathogenic bacteria isolated from clinical samples. Japan beta-lactamase Research Group].
Oguri T; Igari J; Hiramatsu K; Watanabe A; Inoue M; Abe M; Yamane N; Aihara M; Hashimoto H;
Jpn J Antibiot; 2002 Sep; 55 Suppl A():1-28. PubMed ID: 12599526
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin.
Toda M; Arao N; Nohara C; Susaki K; Tachibana A
Antimicrob Agents Chemother; 1985 Apr; 27(4):565-9. PubMed ID: 3890729
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility of clinical isolates in pediatrics to cefpiramide].
Deguchi K
Jpn J Antibiot; 1983 Aug; 36(8):2129-34. PubMed ID: 6655831
[TBL] [Abstract][Full Text] [Related]
20. [In vitro antibacterial activity of cefoperazone-sulbactam].
Zhang Y; Zhang J; Zhou L
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):676-9. PubMed ID: 8731829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
